Azanium;3-methylbutanoate
Common Name: |
Azanium;3-methylbutanoate |
IUPAC Name: |
azanium;3-methylbutanoate |
Molecular Formula: |
C5H13NO2 |
SMILES: |
CC(C)CC(=O)[O-].[NH4+] |
Inchi: |
1S/C5H10O2.H3N/c1-4(2)3-5(6)7;/h4H,3H2,1-2H3,(H,6,7);1H3 |
Inchi Key: |
RKCHCKMAQPJXBM-UHFFFAOYSA-N |
Cas No: |
7563-33-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
119.16 |
Mass (g/mol) |
119.095 |
Molar Refractivity |
31.96 |
Net Charge |
-1 |
HBD |
1 |
HBA |
2 |
Rt Bonds |
2 |
Rings |
|
TPSA |
40.13 |
Hetero Atoms |
2 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
175.30 |
Vapor Pressure (mmHg@25.00 °C) |
0.554 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
1.117 |
iLOGP |
0.00 |
XLOGP3 |
-1.85 |
WLOGP |
0.16 |
MLOGP |
-3.67 |
ESOL Log S |
0.72 |
ESOL Solubility (mg/ml) |
623 |
ESOL Solubility (mol/l) |
5.23 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
1.53 |
Ali Solubility (mg/ml) |
4000 |
Ali Solubility (mol/l) |
33.6 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
-0.41 |
Silicos-IT Solubility (mg/ml) |
46.8 |
Silicos-IT Solubility (mol/l) |
0.39 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-8.34 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
0 |
Plasm Protein Binding |
0.488 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.786 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |